Functional neuroimaging of treatment effects in psychiatry: Methodological challenges and recommendations

International Journal of Neuroscience

Volumn 122, Issue 9, 2012, Pages 483-493

  Dichter, Gabriel S ^a,b   Sikich, Linmarie ^a   Song, Allen ^b   Voyvodic, James ^b   Bodfish, James W ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

clinical trials; fMRI; functional magnetic resonance imaging; neurodevelopmental disorders; psychiatry

Indexed keywords

ACETYLSALICYLIC ACID; NEUROLEPTIC AGENT; PLACEBO; PSYCHOTROPIC AGENT;

ANALYTIC METHOD; ANTICIPATION; ARTICLE; ARTIFACT; ASPERGER SYNDROME; AUTISM; BEHAVIOR; BLOOD OXYGENATION; BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN FUNCTION; BRAIN MATURATION; BRAIN METABOLISM; COGNITION; DATA ANALYSIS; DIZZINESS; DROWSINESS; ENERGY METABOLISM; EXTRAPYRAMIDAL SYMPTOM; FRAGILE X SYNDROME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; INTERVENTION STUDY; MAJOR DEPRESSION; METHODOLOGY; MORPHOMETRICS; NERVE CELL DIFFERENTIATION; PHASE 3 CLINICAL TRIAL (TOPIC); PREDICTION; PSYCHOMETRY; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; REWARD; SCHIZOPHRENIA; SPIN LABELING; TASK PERFORMANCE; TREATMENT RESPONSE; WILLIAMS BEUREN SYNDROME;

BRAIN; BRAIN MAPPING; HALLUCINOGENS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PSYCHOMETRICS;

EID: 84864919037     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.678446     Document Type: Article

References (91)

1. March JS, Silva SG, Compton S, Shapiro M, Califf R, Krishnan R. The case for practical clinical trials in psychiatry. Am J Psychiatry. 2005;162(5):836-846. (Pubitemid 40676194)
2. Summerfelt WT, Meltzer HY. Efficacy vs. effectiveness in psychiatric research. Psychiatr Serv. 1998;49(6):834-835.
3. Webb S. Drugmakers dance with autism. Nat Biotechnol. 2010;28(8):772-774.
4. Dichter G, Sikich, Greeter S, Alderman C, Rittenberg A,Holtzclaw T, et al. fMRI of Citalopram Treatment in Autism. Presented at the 10th Annual International Meeting for Autism Research (IMFAR). 2010 May.
5. Dichter GS, Felder JN, Petty C, Bizzell J, ErnstM, Smoski MJ. The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry. 2009;66(9):886-897.
6. Dichter GS, Felder JN, Smoski MJ. The effects of Brief Behavioral Activation Therapy for Depression on cognitive control in affective contexts: An fMRI investigation. J Affect Disord. 2010.
7. Dichter GS, Felder J, Sikich L, Mahorney S, Bodfish J. fMRI Activation Change Tracks Medication-Induced Reductions in Repetitive Behaviors in Autism: Two Case Studies. Neurocase. 2010;16(4):307-316.
8. SiegleGJ, Carter CS, Thase ME. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry. 2006;163(4):735-738. (Pubitemid 44464587)
9. Tomarken AJ. A Psychometric Perspective on Psychophysiological Measures. Psychological Assessment. 1995;7(3):387-395.
10. Carter CS, Barch DM, Buchanan RW, Bullmore E, Krystal JH, Cohen J, et al. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: An overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry. 2008;64(1):4-10.
11. Caceres A,HallDL, Zelaya FO, Williams SC,Mehta MA.Measuring fMRI reliability with the intra-class correlation coefficient. Neuroimage. 2009;45(3):758-768.
12. Raemaekers M, Vink M, Zandbelt B, van Wezel RJ, Kahn RS, Ramsey NF. Test-retest reliability of fMRI activation during prosaccades and antisaccades. Neuroimage. 2007;36(3): 532-542. (Pubitemid 46907630)
13. Zandbelt BB, Gladwin TE, Raemaekers M, van Buuren M, Neggers SF, Kahn RS, et al. Within-subject variation in BOLD-fMRI signal changes across repeated measurements: quantification and implications for sample size. Neuroimage. 2008;42(1):196-206.
14. Specht K, Willmes K, Shah NJ, Jancke L. Assessment of reliability in functional imaging studies. J Magn Reson Imaging. 2003;17(4):463-471. (Pubitemid 36396949)
15. Aron AR, Gluck MA, Poldrack RA. Long-term test-retest reliability of functional MRI in a classification learning task. Neuroimage. 2006;29(3):1000-1006. (Pubitemid 43121223)
16. Friedman L, Stern H, Brown GG, Mathalon DH, Turner J, Glover GH, et al. Test-retest and between-site reliability in a multicenter fMRI study. Hum Brain Mapp. 2008;29(8): 958-972.
17. Manoach DS, Halpern EF, Kramer TS, Chang Y, Goff DC, Rauch SL, et al. Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am J Psychiatry. 2001;158(6):955-958. (Pubitemid 32547629)
18. Wei X, Yoo SS, Dickey CC, Zou KH, Guttmann CR, Panych LP. Functional MRI of auditory verbal working memory: long-term reproducibility analysis. Neuroimage. 2004;21(3):1000-1008. (Pubitemid 38314962)
19. Wagner K, Frings L, Quiske A, Unterrainer J, Schwarzwald R, Spreer J, et al. The reliability of fMRI activations in the medial temporal lobes in a verbal episodic memory task. Neuroimage. 2005;28(1):122-131. (Pubitemid 41393893)
20. McGonigle DJ, Howseman AM, Athwal BS, Friston KJ, Frackowiak RS, Holmes AP. Variability in fMRI: An examination of intersession differences. Neuroimage. 2000;11(6 Pt 1):708-734. (Pubitemid 30437662)
21. Barch DM, Mathalon DH. Using brain imaging measures in studies of procognitive pharmacologic agents in schizophrenia: Psychometric and quality assurance considerations. Biol Psychiatry. 2011;70(1):13-18.
22. Poldrack RA. Region of interest analysis for fMRI. Soc Cogn Affect Neurosci. 2007;2(1):67-70. (Pubitemid 47090796)
23. Luna B, Velanova K, Geier CF. Methodological approaches in developmental neuroimaging studies. Hum Brain Mapp.2010;31(6):863-871.
24. Casey BJ, Cohen JD, Jezzard P, Turner R, Noll DC, Trainor RJ, et al. Activation of prefrontal cortex in children during a nonspatial working memory task with functional MRI. Neuroimage. 1995;2(3):221-229.
25. Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, GeyerM, et al. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: Proceedings of the third CNTRICS meeting. Schizophr Bull. 2009;35(1):109-114.
26. Sikich L. Psychopharmacologic Treatment Studies in Autism. In E Schopler, N Yirmiya, C Shulman, LM Marcus (Eds.), The research basis for autism intervention. New York: Kluver cademic/ Plenum Publishers 2001.
27. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect. Journal of Clinical Epidemiology. 2001;54(3):217-224. (Pubitemid 32162034)
28. Diederich NJ, Goetz CG. The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies. Neurology. 2008;71(9):677-684.
29. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron. 2008;59(2):195-206. (Pubitemid 352033692)
30. Ernst E. Placebo: New insights into an old enigma. Drug Discov Today. 2007;12(9-10):413-418. (Pubitemid 46636376)
31. Oken BS. The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies. Neurology. 2009;72(23):2053; author reply 2053-2054.
32. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry. 1996;153(1):41-49. (Pubitemid 26026156)
33. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: Treatment outcomes and neural mechanisms. Nat Rev Neurosci. 2008;9(10):788-796.
34. Lehto SM, Tolmunen T, Joensuu M, Saarinen PI, Valkonen-Korhonen M, Vanninen R, et al. Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):229-237.
35. Haut KM, Lim KO, MacDonald A, 3rd. Prefrontal cortical changes following cognitive training in patients with chronic schizophrenia: effects of practice, generalization, and specificity. Neuropsychopharmacology. 2010;35(9):1850-1859.
36. Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry. 2007;164(5):778-788. (Pubitemid 46808533)
37. Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: Preliminary findings. Arch Gen Psychiatry. 2001;58(7):631-640. (Pubitemid 32640857)
38. Zubieta JK, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci. 2009;1156:198-210.
39. Brown GG, Perthen JE, Liu TT, Buxton RB. A primer on functional magnetic resonance imaging. Neuropsychol Rev. 2007;17(2):107-125. (Pubitemid 46889569)
40. Brown GG, Eyler Zorrilla LT, Georgy B, Kindermann SS, Wong EC, Buxton RB. BOLD and perfusion response to fingerthumb apposition after acetazolamide administration: Differential relationship to global perfusion. J Cereb Blood Flow Metab. 2003;23(7):829-837. (Pubitemid 36818690)
41. Buxton RB, Wong EC, Frank LR. Dynamics of blood flow and oxygenation changes during brain activation: The balloon model. Magn Reson Med. 1998;39(6):855-864. (Pubitemid 28237743)
42. van Zijl PC, Eleff SM, Ulatowski JA, Oja JM, Ulug AM, Traystman RJ, et al. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nat Med. 1998;4(2):159-167. (Pubitemid 28137369)
43. Hoge RD, Atkinson J, Gill B, Crelier GR, Marrett S, Pike GB. Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: The deoxyhemoglobin dilution model. Magn Reson Med. 1999;42(5):849-863. (Pubitemid 29521474)
44. Hyder F, Kida I, Behar KL, Kennan RP, Maciejewski PK, Rothman DL. Quantitative functional imaging of the brain: Towards mapping neuronal activity by BOLD fMRI. NMR Biomed. 2001;14(7-8):413-431. (Pubitemid 33150230)
45. Liu TT, Wong EC, Frank LR, Buxton RB. Analysis and design of perfusion-based event-related fMRI experiments. Neuroimage. 2002;16(1):269-282. (Pubitemid 34852489)
46. Restom K, Perthen JE, Liu TT. Calibrated fMRI in the medial temporal lobe during a memory-encoding task. Neuroimage. 2008;40(4):1495-1502.
47. Tomarken AJ. Focus Chapter: Methodological Issues in Psychophysiological Research. In PC Kendall, JN Butcher & GN Holmbeck (Eds.), Handbook of Research Methods in Clinical Psychology (2nd ed.). New York: JohnWiley & Sons, Inc 1999.
48. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression usingmeasurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. (Pubitemid 43050100)
49. Bent S, Hendren RL. Improving the prediction of response to therapy in autism. Neurotherapeutics. 2010;7(3):232-240.
50. Raemaekers M, du Plessis S, Ramsey NF, Weusten JM, Vink M. Test-retest variability underlying fMRI measurements. Neuroimage. 2011.
51. Bookheimer SY. Methodological issues in pediatric neuroimaging. Ment Retard Dev Disabil Res Rev. 2000;6(3):161-165.
52. Gaab N, Gabrieli JD, Deutsch GK, Tallal P, Temple E. Neural correlates of rapid auditory processing are disrupted in children with developmental dyslexia and ameliorated with training: An fMRI study. Restor Neurol Neurosci. 2007;25(3-4):295-310. (Pubitemid 47587113)
53. Small SL, Flores DK, Noll DC. Different neural circuits subserve reading before and after therapy for acquired dyslexia. Brain Lang. 1998;62(2):298-308. (Pubitemid 28264602)
54. Richards TL, Berninger VW. Abnormal fMRI Connectivity in Children with Dyslexia During a Phoneme Task: Before But Not After Treatment 1. J Neurolinguistics.2008;21(4):294-304. (Pubitemid 351598017)
55. Aylward EH, Richards TL, Berninger VW, Nagy WE, Field KM, Grimme AC, et al. Instructional treatment associated with changes in brain activation in children with dyslexia. Neurology.2003;61(2):212-219. (Pubitemid 36875303)
56. Church JA, Petersen SE, Schlaggar BL. The "Task B problem" and other considerations in developmental functional neuroimaging. Hum Brain Mapp. 2010;31(6):852-862.
57. American Psychiatric Association, American Psychiatric Association Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed.). Washington, DC: American Psychiatric Association 2000.
58. Yoo SS, Choi BG, Juh R, Pae CU, Lee CU. Head motion analysis during cognitive fMRI examination: Application in patients with schizophrenia. Neurosci Res. 2005;53(1):84-90. (Pubitemid 41073731)
59. Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A. 1992;89(12):5675-5679.
60. Hunt RH, Thomas KM. Magnetic resonance imaging methods in developmental science: A primer. Dev Psychopathol. 2008;20(4):1029-1051.
61. Hajnal JV, Myers R, Oatridge A, Schwieso JE, Young IR, Bydder GM. Artifacts due to stimulus correlated motion in functional imaging of the brain. Magnetic Resonance in Medicine. 1994;31:283-291. (Pubitemid 24070943)
62. Jezzard P. Physiological noise: Strategies for correction. In C Moonen & PA Bandettini (Eds.), Medical radiology: Functional MRI. New York: Springer-Verlag. 1999:173-181.
63. Voyvodic JT. Real-time fMRI paradigm control, physiology, and behavior combined with near real-time statistical analysis. Neuroimage. 1999;10(2):91-106. (Pubitemid 29379009)
64. Raschle NM, LeeM, Buechler R, Christodoulou JA, ChangM, Vakil M, et al. Making MR imaging child's play - pediatric neuroimaging protocol, guidelines and procedure. J Vis Exp(29). 2009.
65. Kotsoni E, Byrd D, Casey BJ. Special considerations for functional magnetic resonance imaging of pediatric populations. J Magn Reson Imaging. 2006;23(6):877-886. (Pubitemid 43833157)
66. Klonoff EA, Janata JW, Kaufman B. The use of systematic desensitization to overcome resistance to magnetic resonance imaging (MRI) scanning. J Behav Ther Exp Psychiatry. 1986;17(3):189-192. (Pubitemid 16010612)
67. Slifer KJ,Koontz KL,Cataldo MF.Operant-contingency-based preparation of children for functional magnetic resonance imaging.J Appl Behav Anal. 2002;35(2):191-194.
68. Thomas KM, Casey BJ. Functional MRI in pediatrics. In CTW Moonen, PA Bandettini (Eds.), Functional MRI. New York: Springer. 1999:513-523.
69. Casey BJ, Thomas KM, Welsh TF, Badgaiyan RD, Eccard CH, Jennings JR, et al. Dissociation of response conflict, attentional selection, and expectancy with functional magnetic resonance imaging. Proc Natl Acad Sci U S A. 2000;97(15):8728-8733. (Pubitemid 30639741)
70. Castellanos FX, Giedd JN, Hamburger SD, Marsh WL,Rapoport JL. Brain morphometry in Tourette's syndrome: The influence of comorbid attention-deficit/hyperactivity disorder. Neurology. 1996;47(6):1581-1583. (Pubitemid 26422560)
71. Sears LL, Vest C, Mohamed S, Bailey J, Ranson BJ, Piven J. An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23(4):613-624. (Pubitemid 29268406)
72. Cohen JD, Nichols T, Brignone L, Hall SS, Reiss AL. Insular volume reduction in fragile X syndrome. Int J Dev Neurosci. 2011.
73. Martens MA, Reutens DC, Wilson SJ. Auditory cortical volumes and musical ability in Williams syndrome. Neuropsychologia. 2010;48(9):2602-2609.
74. Devlin JT, Poldrack RA. In praise of tedious anatomy. Neuroimage. 2007;37(4):1033-1041; discussion 1050-1038. (Pubitemid 47385255)
75. Durston S, Davidson MC, Tottenham N, Galvan A, Spicer J, Fossella JA, et al. A shift from diffuse to focal cortical activity with development. Dev Sci. 2006;9(1):1-8.
76. Passarotti AM, Sweeney JA, Pavuluri MN. Emotion processing influences workingmemory circuits in pediatric bipolar disorder and attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(10):1064- 1080.
77. Di Martino A, Kelly C, Grzadzinski R, Zuo XN, Mennes M, Mairena MA, et al. Aberrant Striatal Functional Connectivity in Children with Autism. Biol Psychiatry. 2010.
78. Dehaene-Lambertz G, Dehaene S, Hertz-Pannier L. Functional neuroimaging of speech perception in infants. Science. 2002;298(5600):2013-2015. (Pubitemid 35425261)
79. Burgund ED, Kang HC, Kelly JE, Buckner RL, Snyder AZ, Petersen SE, et al. The feasibility of a common stereotactic space for children and adults in fMRI studies of development. Neuroimage. 2002;17(1):184-200.
80. Kang HC, Burgund ED, Lugar HM, Petersen SE, Schlaggar BL. Comparison of functional activation foci in children and adults using a common stereotactic space. Neuroimage. 2003;19(1):16-28. (Pubitemid 36627377)
81. Sanchez CE, Richards JE, Almli CR.NeurodevelopmentalMRI brain templates for children from 2 weeks to 4 years of age. Dev Psychobiol. 2012;54(1):77-91.
82. Yoon U, Fonov VS, Perusse D, Evans AC. The effect of template choice on morphometric analysis of pediatric brain data. Neuroimage. 2009;45(3):769-777.
83. Waber DP, De Moor C, Forbes PW, Almli CR, Botteron KN, Leonard G, et al. The NIH MRI study of normal brain development: Performance of a population based sample of healthy children aged 6 to 18 years on a neuropsychological battery. J Int Neuropsychol Soc. 2007;13(5):729-746. (Pubitemid 47299443)
84. Almli CR, Rivkin MJ, McKinstry RC. The NIH MRI study of normal brain development (Objective-2): Newborns, infants, toddlers, and preschoolers. Neuroimage. 2007;35(1):308-325.
85. Evans AC. The NIH MRI study of normal brain development. Neuroimage. 2006;30(1):184-202. (Pubitemid 43243209)
86. Leppert IR, Almli CR, McKinstry RC, Mulkern RV, Pierpaoli C, Rivkin MJ, et al. T(2) relaxometry of normal pediatric brain development. J Magn Reson Imaging. 2009;29(2):258-267.
87. Wilke M, Schmithorst VJ, Holland SK. Assessment of spatial normalization of whole-brain magnetic resonance images in children. Hum Brain Mapp. 2002;17(1):48-60. (Pubitemid 34966796)
88. Dichter GS, Felder JN, Bodfish JW. Autism is characterized by dorsal anterior cingulate hyperactivation during social target detection. Soc Cogn Affect Neurosci. 2009;4(3):215-226.
89. Shafritz KM, Dichter GS, Baranek GT, Belger A. The neural circuitry mediating shifts in behavioral response and cognitive set in autism. Biological Psychiatry. 2008;63(10):974-980. (Pubitemid 351602271)
90. Glover GH, Li TQ, Ress D. Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR. Magn Reson Med. 2000;44(1):162-167. (Pubitemid 30439852)
91. Hamilton MA. A rating scale for depression. Journal of Neurology and Neurosurgery in Psychiatry. 1960;23:56-62.